Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 11551 - 11575 of 12685 in total
Experimental
Matched Iupac: … 6-(cyclohexylmethoxy)-9H-purin-2-amine …
Experimental
Matched Iupac: … 2-[(diaminomethyl)(methyl)amino]acetic acid …
Experimental
Matched Iupac: … (2R)-2-amino-3-disulfanylpropanoic acid …
Experimental
Matched Iupac: … (2S)-2-amino-3-cyclohexylpropanoic acid …
Experimental
Matched Iupac: … 2-[carboxy(hydroxy)amino]acetic acid …
Experimental
Matched Iupac: … (2S)-2-amino-4-methaneseleninylbutanoic acid …
Experimental
Matched Iupac: … (2S)-2-amino-4-hydroxybutanoic acid …
Experimental
Matched Iupac: … (2S)-2-amino-5-oxopentanoic acid …
N-chlorotaurine is an inhibitor of inducible nitric oxide synthase and IkappaB kinase.
Investigational
Matched Iupac: … 2-(chloroamino)ethane-1-sulfonic acid …
Experimental
Matched Iupac: … (2S)-2-hexanamido-4-hydroxybutanoic acid …
Experimental
Matched Iupac: … 2-(naphthalen-1-yloxy)acetic acid …
Cyclopentamine is a sympathomimetic alkylamine, classified as a vasoconstrictor. Cyclopentamine was an over the counter treatment for nasal congestion in Europe and Australia. It has been widely discontinued due to the safety, effectiveness, and availability of a similar drug, propylhexedrine.
Withdrawn
Matched Iupac: … (1-cyclopentylpropan-2-yl)(methyl)amine …
Experimental
Matched Iupac: … (4,4-diphenylbutan-2-yl)(ethyl)dimethylazanium …
Experimental
Matched Iupac: … benzyl(dodecyl)bis(2-hydroxyethyl)azanium …
Experimental
Matched Iupac: … N-[(azocan-2-yl)methyl]guanidine …
Experimental
Matched Iupac: … aluminium(3+) 2-aminoacetate hydrate dihydroxide …
Experimental
Matched Iupac: … 3,5-dibenzyl-1,3,5-thiadiazinane-2-thione …
CXL-1020 is under investigation in clinical trial NCT01092325 (Safety and Hemodynamic Effects and Pharmacokinetics of CXL-1020 in Patients With Stable Heart Failure).
Investigational
Matched Iupac: … N-hydroxy-2-methanesulfonylbenzene-1-sulfonamide …
Methcathinone is under investigation in clinical trial NCT02617862 (PCI Imaging System in Pediatric Ophthalmology).
Investigational
Matched Iupac: … 2-(methylamino)-1-phenylpropan-1-one …
Mk3207 has been used in trials studying the treatment of Migraine and Migraine Disorders.
Investigational
Matched Iupac: … 2-[(8R)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]decan-9-yl]-N-[(2R)-2'-oxo-1,1',2',3-tetrahydrospiro …
Emricasan is the first caspase inhibitor tested in human which has received orphan drug status by FDA. It is developed by Pfizer and made in such a way that it protects liver cells from excessive apoptosis.
Investigational
Matched Iupac: … (3S)-3-[(2S)-2-{[(2-tert-butylphenyl)carbamoyl]formamido}propanamido]-4-oxo-5-(2,3,5,6-tetrafluorophenoxy …
Investigational
Matched Iupac: … 2-(2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}ethoxy)ethan-1-ol …
Experimental
Matched Iupac: … 1-(3-chloro-4-methylphenyl)-3-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulfanyl]ethyl}urea …
Tipelukast is under investigation for the treatment of IPF and Idiopathic pulmonary fibrosis.
Investigational
Matched Iupac: … 4-(6-acetyl-3-{3-[(4-acetyl-3-hydroxy-2-propylphenyl)sulfanyl]propoxy}-2-propylphenoxy)butanoic acid …
Dexelvucitabine has been used in trials studying the treatment of HIV Infections and Human Immunodeficiency Virus.
Investigational
Matched Iupac: … 4-amino-5-fluoro-1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-1,2-dihydropyrimidin-2-one …
Displaying drugs 11551 - 11575 of 12685 in total